Phenominer Database Results (92 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Clinical Measurement Notes Record ID Study ID
SD-Lepem1Sage-/- percentage of CD4 positive cells expressing interferon gamma control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD4-positive T cell quantity not specified 84 days 11 0.84 % 0.11 0.35 flow cytometry method 0.0 0 104554 2969
SS-Sh2b3em1Mcwi-/- blood T lymphocyte count controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 7.0 x 10E6 cells/ml 0.4 0.8 flow cytometry method 0.0 0 n=4-7 106513 3031
SS/JrHsdMcwi blood B lymphocyte count controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. B cell quantity not specified 63 days 4 1.0 x 10E6 cells/ml 0.2 0.4 flow cytometry method 0.0 0 n=4-7 106514 3031
SS-Sh2b3em1Mcwi-/- blood B lymphocyte count controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. B cell quantity not specified 63 days 4 4.0 x 10E6 cells/ml 0.3 0.6 flow cytometry method 0.0 0 n=4-7 106515 3031
SS-Sh2b3em1Mcwi-/- spleen regulatory T cell count to total T cell count ratio controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 5.2 % 0.3 0.6 flow cytometry method 0.0 0 n=4-7 -tregs blood % 106517 3031
SS-Sh2b3em1Mcwi-/- kidney total CD45 positive leukocyte count controlled sodium chloride content diet (0.4 %) (for 21 days) then controlled sodium chloride content diet (4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. leukocyte quantity not specified 84 days 5 1.84 x 10E6 cells/ml 0.3 0.67 flow cytometry method 0.0 0 n=5-6 106534 3031
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 86.73 % 1.67 5.28 flow cytometry method 0.0 IP injection 1 days 107710 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 2.62 % 0.29 0.92 flow cytometry method 0.0 IP injeciton 1 days saline 107712 3096
WAG/Nov CD3+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 889.52 x10E6/organ 215.59 681.76 flow cytometry method 0.0 0 cd3+ thymocyte 107714 3096
WAG/Nov CD4-CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 74.55 x10E6/organ 18.13 57.33 flow cytometry method 0.0 0 cd4-cd8+ t-cell 107723 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 25.17 % 0.78 2.47 flow cytometry method 0.0 IP injection 1 days cd4+cd25- spleen 107731 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 30.13 % 0.75 2.37 flow cytometry method 0.0 IP injeciton 1 days saline cd3- spleen 107733 3096
WAG/Nov CD11b/c+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 92.63 x10E6/organ 24.28 76.78 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107739 3096
ISIAH CD4+CD25+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 2.02 % 0.1 0.32 flow cytometry method 0.0 0 cd4+cd25+ spleen 107741 3096
ISIAH CD3+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 367.54 x10E6/organ 48.7 154.0 flow cytometry method 0.0 IP injection 1 days cd3+ thymocyte 107764 3096
ISIAH CD4+CD25+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 32.19 x10E6/organ 7.15 22.61 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25+ t-cell 107772 3096
SD-Lepem1Sage-/- blood CD8 lymphocyte count to total lymphocyte count ratio control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD8-positive T cell quantity not specified 84 days 10 5.7 % 1.2 3.79 flow cytometry method 0.0 0 104552 2969
NTac:SD blood CD4 lymphocyte count to total lymphocyte count ratio control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD4-positive T cell quantity not specified 84 days 12 24.8 % 1.28 4.05 flow cytometry method 0.0 0 104549 2969
NTac:SD percentage of CD4 positive cells expressing interferon gamma control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD4-positive T cell quantity not specified 84 days 12 0.42 % 0.05 0.16 flow cytometry method 0.0 0 104553 2969
SD-Lepem1Sage-/- percentage of CD8 positive cells expressing interferon gamma control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD8-positive T cell quantity not specified 84 days 10 7.01 % 0.78 2.47 flow cytometry method 0.0 0 104556 2969
SS/JrHsdMcwi kidney total CD45 positive leukocyte count controlled sodium chloride content diet (0.4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. leukocyte quantity not specified 84 days 5 2.13 x 10E6 cells/ml 0.36 0.8 flow cytometry method 0.0 0 n=5-6 106531 3031
SS/JrHsdMcwi kidney total CD45 positive leukocyte count controlled sodium chloride content diet (0.4 %) (for 21 days) then controlled sodium chloride content diet (4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. leukocyte quantity not specified 84 days 5 3.92 x 10E6 cells/ml 0.42 0.94 flow cytometry method 0.0 0 n=5-6 106535 3031
WAG/Nov CD4+CD8- thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 239.75 x 10E6/organ 50.38 159.32 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd8- t-cell 107718 3096
WAG/Nov CD4-CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 29.08 x10E6/organ 4.63 14.64 flow cytometry method 0.0 IP injection 1 days cd4-cd8+ t-cell 107725 3096
WAG/Nov CD4+CD25+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 40.63 x10E6/organ 7.77 24.57 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25+ t-cell 107727 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 13.89 % 1.48 4.68 flow cytometry method 0.0 0 cd11b/c+ spleen 107735 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 12.4 % 0.81 2.56 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107736 3096
ISIAH CD11b/c+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 8.4 % 1.11 3.51 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107748 3096
ISIAH CD4+CD25+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 34.32 x10E6/organ 11.86 37.5 flow cytometry method 0.0 IP injection 1 days cd4+cd25+ spleen 107752 3096
ISIAH CD4-CD25+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 12.69 x 10E6/organ 4.65 14.7 flow cytometry method 0.0 IP injection 1 days cd4-cd25+ spleen 107755 3096
ISIAH CD3+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 214.09 x10E6/organ 11.49 36.33 flow cytometry method 0.0 IP injeciton 1 days saline cd3+ spleen 107757 3096
NTac:SD blood CD8 lymphocyte count to total lymphocyte count ratio control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD8-positive T cell quantity not specified 84 days 10 8.5 % 1.2 3.79 flow cytometry method 0.0 0 104551 2969
NTac:SD percentage of CD8 positive cells expressing interferon gamma control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD8-positive T cell quantity not specified 84 days 10 5.18 % 0.38 1.2 flow cytometry method 0.0 0 104555 2969
SS-Sh2b3em1Mcwi-/- blood regulatory T cell count to total T cell count ratio controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 4.9 % 0.1 0.2 flow cytometry method 0.0 0 n=4-7 -tregs spleen % 106519 3031
SS/JrHsdMcwi kidney total CD3 positive T cell count controlled sodium chloride content diet (0.4 %) (for 84 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 84 days 5 0.21 x 10E6 cells/ml 0.03 0.07 flow cytometry method 0.0 0 n=5-6 (tissue T cell count) 106533 3031
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 0.34 % 0.09 0.28 flow cytometry method 0.0 0 107705 3096
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 6.34 % 1.27 4.02 flow cytometry method 0.0 IP injection 1 days 107713 3096
WAG/Nov CD4+CD8- thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 199.43 x 10E6/organ 33.75 106.73 flow cytometry method 0.0 0 cd4+cd8- t-cell 107717 3096
WAG/Nov CD4+CD8- thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 112.44 x 10E6/organ 24.64 77.92 flow cytometry method 0.0 IP injection 1 days cd4+cd8- t-cell 107719 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 27.9 % 0.69 2.18 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25- spleen 107730 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 29.81 % 0.57 1.8 flow cytometry method 0.0 0 cd3+ spleen 107732 3096
WAG/Nov CD11b/c+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 19.14 % 1.71 5.41 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107737 3096
ISIAH CD45RA+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 28.7 % 1.12 3.54 flow cytometry method 0.0 IP injection 1 days cd45 RA+ spleen 107746 3096
ISIAH CD11b/c+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 9.4 % 1.61 5.09 flow cytometry method 0.0 0 cd11b/c+ spleen 107747 3096
ISIAH CD11b/c+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 17.43 % 2.17 6.86 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107749 3096
ISIAH CD4+CD25+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 13.99 x10E6/organ 2.0 6.32 flow cytometry method 0.0 0 cd4+cd25+ spleen 107750 3096
ISIAH CD4-CD25+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 3.21 x 10E6/organ 0.57 1.8 flow cytometry method 0.0 IP injeciton 1 days saline cd4-cd25+ spleen 107754 3096
ISIAH CD11b/c+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 269.9 x10E6/organ 92.85 293.62 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107761 3096
ISIAH CD3+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 611.58 x10E6/organ 83.15 262.94 flow cytometry method 0.0 0 cd3+ thymocyte 107762 3096
ISIAH CD4-CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 48.72 x10E6/organ 13.72 43.39 flow cytometry method 0.0 0 cd4-cd8+ t-cell 107768 3096
ISIAH CD4+CD25+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 23.15 x10E6/organ 6.34 20.05 flow cytometry method 0.0 0 cd4+cd25+ t-cell 107771 3096
SS/JrHsdMcwi blood T lymphocyte count controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 3.3 x 10E6 cells/ml 0.5 1.0 flow cytometry method 0.0 0 n=4-7 106512 3031
SD-Lepem1Sage-/- blood CD4 lymphocyte count to total lymphocyte count ratio control condition Vaira S, et al., Endocrinology. 2012 Nov;153(11):5622-8. doi: 10.1210/en.2012-1462. Epub 2012 Sep 4. CD4-positive T cell quantity not specified 84 days 11 17.16 % 2.2 6.96 flow cytometry method 0.0 0 104550 2969
SS/JrHsdMcwi blood regulatory T cell count to total T cell count ratio controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 4.0 % 0.1 0.2 flow cytometry method 0.0 0 n=4-7 -tregs spleen % 106518 3031
SS/JrHsdMcwi kidney total CD3 positive T cell count controlled sodium chloride content diet (0.4 %) (for 42 days) then controlled sodium chloride content diet (4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 84 days 5 0.42 x 10E6 cells/ml 0.04 0.09 flow cytometry method 0.0 0 n=5-6 (tissue T cell count) 106532 3031
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 0.45 % 0.12 0.38 flow cytometry method 0.0 IP injection 1 days saline 107706 3096
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 92.68 % 0.6 1.9 flow cytometry method 0.0 0 107708 3096
WAG/Nov G0 stage diploid thymocyte count to total thymocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 93.31 % 0.93 2.94 flow cytometry method 0.0 IP injection 1 days saline 107709 3096
WAG/Nov CD4+CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 176.61 x10E6/organ 32.55 102.93 flow cytometry method 0.0 IP injection 1 days cd4+cd8+ t-cell 107722 3096
WAG/Nov CD4+CD25+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 20.02 x10E6/organ 4.65 14.7 flow cytometry method 0.0 IP injection 1 days cd4+cd25+ t-cell 107728 3096
ISIAH CD4+CD25+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 1.7 % 0.17 0.54 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25+ spleen 107742 3096
ISIAH CD45RA+ splenocyte count to total splenocyte count ratio vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 34.86 % 1.36 4.3 flow cytometry method 0.0 IP injeciton 1 days saline cd45 RA+ spleen 107745 3096
ISIAH CD4+CD25+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 9.83 x10E6/organ 0.94 2.97 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd25+ spleen 107751 3096
ISIAH CD4-CD25+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 4.38 x 10E6/organ 0.82 2.59 flow cytometry method 0.0 0 cd4-cd25+ spleen 107753 3096
ISIAH CD3+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 252.6 x10E6/organ 32.4 102.46 flow cytometry method 0.0 0 cd3+ spleen 107756 3096
ISIAH CD4-CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 63.99 x10E6/organ 6.25 19.76 flow cytometry method 0.0 IP injeciton 1 days saline cd4-cd8+ t-cell 107769 3096
SS/JrHsdMcwi blood mononuclear cell count controlled sodium chloride content diet (0.4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. leukocyte quantity not specified 84 days 4 5.9 x 10E6 cells/ml 0.9 1.8 flow cytometry method 0.0 0 n=4-7 106510 3031
SS-Sh2b3em1Mcwi-/- blood mononuclear cell count controlled sodium chloride content diet (0.4 %) (for 21 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. leukocyte quantity not specified 84 days 4 14.7 x 10E6 cells/ml 0.6 1.2 flow cytometry method 0.0 0 n=4-7 106511 3031
SS/JrHsdMcwi spleen regulatory T cell count to total T cell count ratio controlled sodium chloride content diet (0.4 %) (for 42 days) Rudemiller NP, et al., Hypertension. 2015 May;65(5):1111-7. doi: 10.1161/HYPERTENSIONAHA.114.04736. Epub 2015 Mar 16. T cell quantity not specified 63 days 4 3.5 % 0.1 0.2 flow cytometry method 0.0 0 n=4-7 -tregs blood % 106516 3031
WAG/Nov G2/M stage tetraploid thymocyte count to total thymocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 3.13 % 0.46 1.45 flow cytometry method 0.0 0 107711 3096
WAG/Nov CD3+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 1021.26 x10E6/organ 145.57 460.33 flow cytometry method 0.0 IP injeciton 1 days saline cd3+ thymocyte 107715 3096
WAG/Nov CD3+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 376.49 x10E6/organ 64.81 204.95 flow cytometry method 0.0 IP injection 1 days cd3+ thymocyte 107716 3096
WAG/Nov CD4+CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 512.96 x10E6/organ 161.9 511.97 flow cytometry method 0.0 0 cd4+cd8+ t-cell 107720 3096
WAG/Nov CD4+CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 596.53 x10E6/organ 88.59 280.15 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd8+ t-cell 107721 3096
WAG/Nov CD4-CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 74.18 x10E6/organ 11.97 37.85 flow cytometry method 0.0 IP injeciton 1 days saline cd4-cd8+ t-cell 107724 3096
WAG/Nov CD4+CD25+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 39.38 x10E6/organ 6.0 18.97 flow cytometry method 0.0 0 cd4+cd25+ t-cell 107726 3096
WAG/Nov CD4+CD25- splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 25.7 % 1.16 3.67 flow cytometry method 0.0 0 cd4+cd25- spleen 107729 3096
WAG/Nov CD3+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 23.34 % 2.11 6.67 flow cytometry method 0.0 IP injection 1 days cd3+ spleen 107734 3096
WAG/Nov CD11b/c+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 86.13 x10E6/organ 25.02 79.12 flow cytometry method 0.0 0 cd11b/c+ spleen 107738 3096
WAG/Nov CD11b/c+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 253.98 x10E6/organ 53.16 168.11 flow cytometry method 0.0 IP injection 1 days cd11b/c+ spleen 107740 3096
ISIAH CD4+CD25+ splenocyte count to total splenocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 2.19 % 0.11 0.35 flow cytometry method 0.0 IP injection 1 days cd4+cd25+ spleen 107743 3096
ISIAH CD45RA+ splenocyte count to total splenocyte count ratio control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 35.23 % 0.8 2.53 flow cytometry method 0.0 0 cd45 RA+ spleen 107744 3096
ISIAH CD3+ splenocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 577.13 x10E6/organ 1.9 6.01 flow cytometry method 0.0 IP injection 1 days cd3+ spleen 107758 3096
ISIAH CD11b/c+ splenocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 66.35 x10E6/organ 17.18 54.33 flow cytometry method 0.0 0 cd11b/c+ spleen 107759 3096
ISIAH CD11b/c+ splenocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. splenocyte morphology trait male 150 days-180 days 10 50.17 x10E6/organ 10.65 33.68 flow cytometry method 0.0 IP injeciton 1 days saline cd11b/c+ spleen 107760 3096
ISIAH CD3+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 716.82 x10E6/organ 91.79 290.27 flow cytometry method 0.0 IP injeciton 1 days saline cd3+ thymus 107763 3096
ISIAH CD4+CD8+ thymocyte count control condition Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 363.84 x10E6/organ 38.81 122.73 flow cytometry method 0.0 0 cd4+cd8+ t-cell 107765 3096
ISIAH CD4+CD8+ thymocyte count vehicle control condition (2 ml/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 419.0 x10E6/organ 50.57 159.92 flow cytometry method 0.0 IP injeciton 1 days saline cd4+cd8+ t-cell 107766 3096
ISIAH CD4+CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 215.5 x10E6/organ 27.45 86.8 flow cytometry method 0.0 IP injection 1 days cd4+cd8+ t-cell 107767 3096
ISIAH CD4-CD8+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 26.42 x10E6/organ 3.96 12.52 flow cytometry method 0.0 IP injection 1 days cd4-cd8+ t-cell 107770 3096
ISIAH CD4+CD25+ thymocyte count lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. thymocyte quantity male 150 days-180 days 10 15.61 x10E6/organ 1.96 6.2 flow cytometry method 0.0 IP injection 1 days cd4+cd25+ t-cell 107773 3096
WAG/Nov apoptotic hypodiploid thymocyte count to total thymocyte count ratio lipopolysaccharide (500 ug/kg) (for 1 days) Shurligina AV, et al., Bull Exp Biol Med. 2013 Aug;155(4):421-4. doi: 10.1007/s10517-013-2167-4. T cell development trait male 150 days-180 days 10 1.88 % 0.39 1.23 flow cytometry method 0.0 IP injection 1 days 107707 3096